Comparison
1q24q25 Microdeletion Syndrome Cn252652 vs 12q14 Microdeletion Syndrome C4305140
Clinical comparison between 1q24q25 Microdeletion Syndrome CN252652 and 12q14 Microdeletion Syndrome for differential diagnosis and treatment planning.
1q24q25 Microdeletion Syndrome Cn252652
A genetic condition involving deletion of material from chromosome 1. Leads to developmental delays, growth issues, and various medical concerns. Treatment addresses individual symptoms.
12q14 Microdeletion Syndrome C4305140
A rare genetic deletion involving a segment of chromosome 12. It may lead to developmental delays, learning difficulties, and other health issues. Management is individualized and focuses on supportive therapies.
6 comparison axes
Onset
1q24q25 Microdeletion Syndrome Cn252652
Variable
12q14 Microdeletion Syndrome C4305140
0-2
Onset patterns differ
Severity
1q24q25 Microdeletion Syndrome Cn252652
severe
12q14 Microdeletion Syndrome C4305140
moderate
Different severity levels
Chronic
1q24q25 Microdeletion Syndrome Cn252652
Chronic
12q14 Microdeletion Syndrome C4305140
Chronic
Differing course
Communicable
1q24q25 Microdeletion Syndrome Cn252652
No
12q14 Microdeletion Syndrome C4305140
No
Different transmission
Body System
1q24q25 Microdeletion Syndrome Cn252652
congenital
12q14 Microdeletion Syndrome C4305140
congenital
Same/different system
Category
1q24q25 Microdeletion Syndrome Cn252652
rare-disease
12q14 Microdeletion Syndrome C4305140
genetic
Different category
Bottom line
1q24q25-microdeletion-syndrome-CN252652 and 12q14-microdeletion-syndrome-C4305140 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 1q24q25 Microdeletion Syndrome Cn252652 | 12q14 Microdeletion Syndrome C4305140 | Discriminating power |
|---|---|---|---|
| Developmental concerns | Developmental delay with growth issues and varied medical concerns is described. | Developmental delay and learning difficulty may occur. | Low |
| Reported severity | Labeled severe, but individual course is not established. | Labeled moderate, with individualized supportive needs. | Moderate |
| Chromosomal locus | Involves deletion of material from chromosome 1q24q25. | Involves deletion of a segment of chromosome 12q14. | High |
When to favor each condition
Choose 1q24q25 Microdeletion Syndrome Cn252652 when
Genetic testing identifies a 1q24q25 deletion
The chromosome region distinguishes this condition from a 12q14 deletion.
High
Severe congenital presentation needs a genetic explanation
Severity may fit the supplied label, but testing is required.
Low
Variable age at recognition
Supplied onset is variable rather than limited to ages 0–2.
Moderate
Choose 12q14 Microdeletion Syndrome C4305140 when
Genetic testing identifies a 12q14 deletion
Confirmation of chromosome 12q14 is the key distinction.
High
Concern begins between ages 0 and 2
This matches the supplied onset axis, but is not diagnostic alone.
Moderate
Learning difficulty is the main reported issue
This aligns with the supplied description, pending genetic confirmation.
Low
How key tests differ
| Test | 1q24q25 Microdeletion Syndrome Cn252652 | 12q14 Microdeletion Syndrome C4305140 | Interpretation |
|---|---|---|---|
| Chromosomal microarray | May detect a deletion involving 1q24q25. | May detect a deletion involving 12q14. | The reported locus, not symptoms alone, distinguishes the conditions. |
| Karyotype | May miss a small 1q24q25 deletion. | May miss a small 12q14 deletion. | A normal karyotype does not exclude either microdeletion. |
| Clinical genetics review | Integrates growth, development, and chromosome 1 findings. | Integrates learning, development, and chromosome 12 findings. | Clinician interpretation is required; no definitive symptom pattern is established. |
Prognosis comparison
1q24q25 Microdeletion Syndrome Cn252652
- Outcome
- Long-term outcome is not established; supplied severity is severe.
- Factors
- Associated medical concerns, growth, development, and available support may influence course.
12q14 Microdeletion Syndrome C4305140
- Outcome
- Long-term outcome is not established; supplied severity is moderate.
- Factors
- Learning needs, other health issues, and supportive therapies may influence course.
Time frame: Both are described as chronic; no reliable time frame is supplied.
Prognosis should be individualized by a clinician.
Complications comparison
| Complication | Presentation |
|---|---|
| Growth or medical concerns | Growth issues and varied concerns are described. Other health issues may occur, but specifics are not supplied. Exact complications and frequencies are not established. |
| Learning needs | Developmental delay may require support. Learning difficulties may require support. Needs should be assessed individually. |
| Transmission risk | Not communicable. Not communicable. Neither is an infection; inheritance counseling requires genetics review. |
Patient education highlights
- HighDiagnosis
An abnormal or suspected genetic finding needs confirmation and clinician interpretation.
- HighCare
Management is individualized and focuses on developmental, growth, learning, and medical needs.
- MediumInfection
Neither condition is communicable through ordinary contact.